Brevicillin® drops

Brevicillin® Drops is a precision probiotic supplement based on the typified strain Bifidobacterium breve PRL2020, specifically developed to be co-administered with Amoxicillin or Amoxicillin/Clavulanic acid. Unlike conventional probiotics, PRL2020 is resistant to these antibiotics, making it a targeted solution to counteract microbiota disruption during antibiotic therapy. This unique characteristic allows Brevicillin® to actively support the preservation of gut microbiota balance, helping to limit the negative impact of antibiotics and associated intestinal symptoms. Clinical evidence in pediatric populations shows a significant reduction in antibiotic-associated diarrhea and a positive modulation of microbiota composition, including increased Bifidobacteria and control of Proteobacteria overgrowth. The drops formulation, based on an oil suspension, ensures enhanced probiotic stability and enables precise and easy administration, even in very young children, making it ideal for daily use during antibiotic treatment. Brevicillin® is also available in stick packs and capsules, delivering 20 billion CFU of B. breve PRL2020, designed for older children, adolescents and adults, with flexible administration options tailored to different preferences.